Published: Mon, March 23, 2020
Health Care | By Cedric Leonard

Global COVID-19 Death Toll Exceeds 10000

Global COVID-19 Death Toll Exceeds 10000

The mRNA vaccine works by introducing a genetic sequence for coding a disease's specific antigen, such as the spike protein on the surface of the novel coronavirus. "There has to be fair and equitable access to that vaccine for everybody", Ryan said, adding that the world will be protected from coronavirus only if everybody is vaccinated. The report reads like, "Our most significant conclusion is that mitigation is unlikely to be feasible without emergency surge capacity limits of the United Kingdom and U.S. healthcare systems being exceeded many times over".

The team has been awarded $500,000 by the US Food and Drug Administration (FDA) to bolster the global response to coronavirus vaccine and treatment development. The trial hopes to enroll 45 healthy adult volunteers ages 18 to 55. They would be given two vaccines, one month apart.

Professor Adrian Hill, a leading researcher from Oxford University who is involved with developing the vaccine has been quoted as telling the Guardian that, "this is not a normal situation". Till now, only four patients have been given the vaccine and the researches said that even though the vaccine was incorporated in 'record time, ' it will take months to nearly a year to know the result, whether this vaccine is actually working or not.

Chinese scientists are also researching other innovative types of vaccines, including an influenza vector vaccine that can be administered like a nose drop, a subunit protein vaccine that can be easily mass-produced and an antibody vaccine that can provide strong, short term immunity for around three weeks, he said.

FROM the USA to China and in between, over 35 drug makers are fighting for a vaccine that can prevent new coronavirus (COVID-19).

Dr. John Tregoning, an expert in infectious diseases from Imperial College London, said, "This vaccine uses pre-existing technology".

Singapore to ban on all short-term visitors in new virus measures
For work pass holders, only those involved in essential services like transport and healthcare would be allowed in. A man scans a visitor's forehead to check his temperature before entering the Asia Square Tower in Singapore .


"Every day matters. We have taken these decisions to take the risk because we believe it is the right thing to do". Human trials start this summer.

According to The Sun Online, the Oxford vaccine is one of five vaccines in development around the globe. "Not even close. We're also racing to develop antiviral therapies and other treatments".

"A Phase 1 clinical trial evaluating an investigational vaccine created to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle".

"We've got to be very, very, very cautious in growing any product that we will inject into doubtlessly a lot of the world's inhabitants", he stated, including that the primary human trials on a vaccine that began this week in the USA have been "unprecedented in pace".

At this moment, the team responsible for the project is in search for volunteers, so that the tests on humans at the April month. As in all times of crisis, misinformation can spread easily.

"In general, vaccine development at our universities is proceeding smoothly in accordance with relevant laws and regulations", he said.

Like this: